NEW GUIDANCE ON THERAPEUTIC DRUG MONITORING; POTENTIAL CLINICAL AND COST IMPLICATIONS

被引：0
|
作者：
Felwick, Richard [1 ]
Johnson, Heather [1 ]
Dewhurst, Hannah [1 ]
Cadogan, Ernest [1 ]
Hovell, Chris [1 ]
Weaver, Sean [1 ]
McLaughlin, Simon [1 ]
机构：
[1] Royal Bournemouth Hosp, Bournemouth, Dorset, England
来源：
GUT | 2018年 / 67卷
关键词：
D O I：
10.1136/gutjnl-2018-BSGAbstracts.150
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PWE-018
引用
收藏
页码：A76 / A77
页数：2
相关论文
共 50 条
  • [21] Toxicodynamics of Itraconazole: Implications for Therapeutic Drug Monitoring
    Lestner, Jodi M.
    Roberts, Steven A.
    Moore, Caroline B.
    Howard, Susan J.
    Denning, David W.
    Hope, William W.
    CLINICAL INFECTIOUS DISEASES, 2009, 49 (06) : 928 - 930
  • [22] Implications of methodologic bias for therapeutic drug monitoring
    Linder, MW
    Elin, RJ
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1999, 123 (10) : 931 - 932
  • [23] Nanosensors for therapeutic drug monitoring: implications for transplantation
    Shafiee, Ashkan
    Ghadiri, Elham
    Kassis, Jareer
    Atala, Anthony
    NANOMEDICINE, 2019, 14 (20) : 2735 - 2747
  • [24] Asparaginase pharmacokinetics and implications of therapeutic drug monitoring
    Asselin, Barbara
    Rizzari, Carmelo
    LEUKEMIA & LYMPHOMA, 2015, 56 (08) : 2273 - 2280
  • [25] Reporting units for therapeutic drug monitoring: a correctable source of potential clinical error
    Jones, Graham R. D.
    MEDICAL JOURNAL OF AUSTRALIA, 2007, 186 (08) : 420 - 421
  • [26] Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of etanercept
    Llinares-Tello, Francisca
    Rosas-Gomez de Salazar, Jose
    Miguel Senabre-Gallego, Jose
    Santos-Soler, Gregorio
    Santos-Ramirez, Carlos
    Salas-Heredia, Esteban
    Molina-Garcia, Juan
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (10) : E279 - E282
  • [27] Drug metabolism in liver disease: Implications for therapeutic drug monitoring
    Sonne, J
    THERAPEUTIC DRUG MONITORING, 1996, 18 (04) : 397 - 401
  • [28] Potential drug-drug interactions of antifungal prophylaxis and midostaurin in FLT3-mutated acute myeloid leukaemia - clinical implications of therapeutic drug monitoring
    Joisten, C.
    Mueller, C.
    Mellinghoff, S.
    Maurer, C.
    Kreuzer, K. A.
    Wiesen, M.
    Koehler, P.
    Cornely, O. A.
    Stemler, J.
    MYCOSES, 2023, 66 : 25 - 26
  • [29] Paclitaxel therapeutic drug monitoring - International association of therapeutic drug monitoring and clinical toxicology recommendations
    Hertz, Daniel L.
    Joerger, Markus
    Bang, Yung-Jue
    Mathijssen, Ron H.
    Zhou, Caicun
    Zhang, Li
    Gandara, David
    Stahl, Michael
    Monk, Bradley J.
    Jaehde, Ulrich
    Beumer, Jan H.
    EUROPEAN JOURNAL OF CANCER, 2024, 202
  • [30] A New Application of MALDI Biotyper for a Potential Use in Therapeutic Drug Monitoring of Voriconazole
    Falces-Romero, Iker
    Mingorance, Jesus
    Garcia-Rodriguez, Julio
    Cendejas-Bueno, Emilio
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (08)
12345